Korvest Ltd (ASX:KOV)
14.28
+0.13 (0.92%)
Aug 13, 2025, 4:10 PM AEST
Ligand Pharmaceuticals Balance Sheet
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | 2016 - 2020 |
Cash & Equivalents | 13.03 | 6.79 | 8.94 | 3.56 | 6.69 | Upgrade |
Short-Term Investments | 0.28 | 0.28 | 0.28 | 0.28 | 0.28 | Upgrade |
Cash & Short-Term Investments | 13.31 | 7.06 | 9.22 | 3.83 | 6.97 | Upgrade |
Cash Growth | 88.35% | -23.34% | 140.54% | -45.00% | 3.26% | Upgrade |
Accounts Receivable | 21.36 | 22.74 | 18.86 | 16.87 | 14.15 | Upgrade |
Other Receivables | 0.6 | - | - | - | - | Upgrade |
Receivables | 21.96 | 22.74 | 18.86 | 16.87 | 14.15 | Upgrade |
Inventory | 18.5 | 16.99 | 16.79 | 20.46 | 12.45 | Upgrade |
Prepaid Expenses | 0.58 | 0.59 | 0.54 | 0.31 | 0.3 | Upgrade |
Total Current Assets | 54.34 | 47.37 | 45.41 | 41.47 | 33.87 | Upgrade |
Property, Plant & Equipment | 34.81 | 30.74 | 25.25 | 24.44 | 22.66 | Upgrade |
Long-Term Accounts Receivable | 1.24 | 1.43 | - | - | - | Upgrade |
Total Assets | 90.38 | 79.55 | 70.66 | 65.91 | 56.52 | Upgrade |
Accounts Payable | 6.22 | 4.34 | 4.68 | 5.15 | 4.94 | Upgrade |
Accrued Expenses | 4.01 | 3.61 | 3.27 | 3.14 | 2.93 | Upgrade |
Current Portion of Leases | 1.16 | 1.16 | 0.78 | 0.79 | 0.79 | Upgrade |
Current Income Taxes Payable | 0.96 | 1.29 | 0.66 | 1.58 | 1.22 | Upgrade |
Other Current Liabilities | 5.75 | 4.96 | 4.99 | 4.08 | 3.57 | Upgrade |
Total Current Liabilities | 18.1 | 15.35 | 14.39 | 14.74 | 13.44 | Upgrade |
Long-Term Leases | 8.72 | 8.32 | 4.42 | 4.68 | 5.45 | Upgrade |
Long-Term Deferred Tax Liabilities | 2.34 | 2.08 | 2.46 | 1.84 | 1.02 | Upgrade |
Other Long-Term Liabilities | - | - | - | 0.56 | 0.49 | Upgrade |
Total Liabilities | 29.56 | 26.1 | 21.62 | 22.09 | 20.6 | Upgrade |
Common Stock | 14.53 | 14.46 | 14.4 | 14.33 | 14.27 | Upgrade |
Retained Earnings | 36.5 | 30.98 | 26.93 | 22.69 | 16.51 | Upgrade |
Comprehensive Income & Other | 9.79 | 8.01 | 7.71 | 6.8 | 5.15 | Upgrade |
Shareholders' Equity | 60.82 | 53.45 | 49.04 | 43.83 | 35.93 | Upgrade |
Total Liabilities & Equity | 90.38 | 79.55 | 70.66 | 65.91 | 56.52 | Upgrade |
Total Debt | 9.88 | 9.48 | 5.19 | 5.47 | 6.23 | Upgrade |
Net Cash (Debt) | 3.42 | -2.42 | 4.02 | -1.64 | 0.73 | Upgrade |
Net Cash Growth | - | - | - | - | -63.41% | Upgrade |
Net Cash Per Share | 0.29 | -0.21 | 0.34 | -0.14 | 0.06 | Upgrade |
Filing Date Shares Outstanding | 11.76 | 11.68 | 11.58 | 11.47 | 11.34 | Upgrade |
Total Common Shares Outstanding | 11.76 | 11.68 | 11.58 | 11.45 | 11.33 | Upgrade |
Working Capital | 36.24 | 32.02 | 31.02 | 26.73 | 20.43 | Upgrade |
Book Value Per Share | 5.17 | 4.58 | 4.24 | 3.83 | 3.17 | Upgrade |
Tangible Book Value | 60.82 | 53.45 | 49.04 | 43.83 | 35.93 | Upgrade |
Tangible Book Value Per Share | 5.17 | 4.58 | 4.24 | 3.83 | 3.17 | Upgrade |
Land | 12.6 | 10.73 | 10.73 | 10 | 8.23 | Upgrade |
Machinery | 33 | 30.5 | 26.76 | 26.44 | 26.03 | Upgrade |
Construction In Progress | 2.73 | 1.68 | 1.24 | - | - | Upgrade |
Updated Jan 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.